Decoding the Pluripotency Network: The Emergence of New Transcription Factors
Overview
Authors
Affiliations
Since the successful isolation of mouse and human embryonic stem cells (ESCs) in the past decades, massive investigations have been conducted to dissect the pluripotency network that governs the ability of these cells to differentiate into all cell types. Beside the core Oct4-Sox2-Nanog circuitry, accumulating regulators, including transcription factors, epigenetic modifiers, microRNA and signaling molecules have also been found to play important roles in preserving pluripotency. Among the various regulations that orchestrate the cellular pluripotency program, transcriptional regulation is situated in the central position and appears to be dominant over other regulatory controls. In this review, we would like to summarize the recent advancements in the accumulating findings of new transcription factors that play a critical role in controlling both pluripotency network and ESC identity.
Yu H, Zhang Y, Zhang Y, Chen S, Li Z, Pi W Vet Sci. 2024; 11(9).
PMID: 39330776 PMC: 11435492. DOI: 10.3390/vetsci11090397.
Canalizing kernel for cell fate determination.
Kim N, Lee J, Kim J, Kim Y, Cho K Brief Bioinform. 2024; 25(5).
PMID: 39171985 PMC: 11339868. DOI: 10.1093/bib/bbae406.
Nakhaei-Nejad M, Trinity L, Jabbari H, Pasdar M, Jahroudi N J Clin Med. 2021; 10(18).
PMID: 34575270 PMC: 8471316. DOI: 10.3390/jcm10184161.
Wu L, Zhao G, Xu S, Kuang J, Ming J, Wu G J Biol Chem. 2020; 296:100022.
PMID: 33144328 PMC: 7948406. DOI: 10.1074/jbc.RA120.014598.
MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma.
Zargari S, Negahban Khameneh S, Rad A, Forghanifard M BMC Cancer. 2020; 20(1):789.
PMID: 32819319 PMC: 7441725. DOI: 10.1186/s12885-020-07307-0.